1199TiP Phase I trial of in situ vaccination with autologous CCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC
| Autor: | Lisberg, A.E., Liu, B., Salehi-Rad, R., Lee, J.M., Tran, L., Krysan, K., Lim, R., Dumitras, C., Jiang, Z., Abtin, F., Suh, R., Genshaft, S., Oh, S., Fishbein, G.A., O'Higgins, C.M., Greenwald, D., Goldman, J.W., Elashoff, D., Garon, E.B., Dubinett, S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1096-S1097 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|